VanEck Biotech ETF (BBH) — ETF Analysis on Winston

Key Facts

• Issuer: VanEck
• Category: Equity
• Asset Class: Equity
• Price: $241.23
• Expense Ratio: 35.00%
• Assets Under Management: $399M
• Number of Holdings: 25
• Inception Date: 2011-12-20
• Currency: USD

Winston Score

VanEck Biotech ETF has a Winston Score of 57 out of 100.

Performance

• 1-Year Return: 46.79%
• 3-Year Return: 50.01%
• 5-Year Return: 11.92%

Top Holdings

Amgen Inc (N/A%), Gilead Sciences Inc (N/A%), Vertex Pharmaceuticals Inc (N/A%), Regeneron Pharmaceuticals Inc (N/A%), Revolution Medicines Inc (N/A%)

Sector Breakdown

Healthcare (N/A%)